Viewing Study NCT01687218


Ignite Creation Date: 2025-12-25 @ 4:49 AM
Ignite Modification Date: 2026-01-11 @ 3:29 AM
Study NCT ID: NCT01687218
Status: COMPLETED
Last Update Posted: 2021-06-24
First Post: 2012-08-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Sponsor: CONRAD
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-09-25
Start Date Type: ACTUAL
Primary Completion Date: 2015-05-26
Primary Completion Date Type: ACTUAL
Completion Date: 2015-05-26
Completion Date Type: ACTUAL
First Submit Date: 2012-08-27
First Submit QC Date: None
Study First Post Date: 2012-09-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-12-07
Results First Submit QC Date: None
Results First Post Date: 2017-02-01
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-06-22
Last Update Post Date: 2021-06-24
Last Update Post Date Type: ACTUAL